HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lauren M Jansson Selected Research

Neonatal Abstinence Syndrome

1/2022Standardizing the Clinical Definition of Opioid Withdrawal in the Neonate.
11/2021Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
11/2021Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
1/2021Definitions of neonatal abstinence syndrome in clinical studies of mothers and infants: an expert literature review.
1/2019Maternal buprenorphine treatment during pregnancy and maternal physiology.
1/2019Neonatal Abstinence Syndrome.
1/2018Prenatal buprenorphine exposure and neonatal neurobehavioral functioning.
11/2017Maternal buprenorphine treatment and infant outcome.
6/2017Male Sex Associated With Increased Risk of Neonatal Abstinence Syndrome.
11/2016A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi survey.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lauren M Jansson Research Topics

Disease

27Neonatal Abstinence Syndrome
01/2022 - 07/2005
9Opioid-Related Disorders (Opiate Addiction)
01/2019 - 09/2007
6Substance-Related Disorders (Drug Abuse)
11/2017 - 10/2004
3Birth Weight (Birth Weights)
11/2017 - 12/2011
1Muscle Hypertonia
01/2022
1Tremor (Tremors)
01/2022
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
03/2020
1Weight Gain
01/2020
1Strabismus (Squint)
08/2017
1Hepatitis C
06/2017
1Infections
06/2017
1Congenital Abnormalities (Deformity)
09/2011
1Premature Birth (Birth, Premature)
12/2010
1Lethargy
11/2010

Drug/Important Bio-Agent (IBA)

24nasIBA
01/2022 - 07/2005
21Opioid Analgesics (Opioids)IBA
01/2022 - 07/2005
10Methadone (Dolophine)FDA LinkGeneric
08/2017 - 07/2005
7Buprenorphine (Subutex)FDA LinkGeneric
01/2019 - 07/2005
3Pharmaceutical PreparationsIBA
12/2010 - 10/2004
2Morphine (MS Contin)FDA LinkGeneric
01/2014 - 09/2013
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2017
1Naltrexone (ReVia)FDA LinkGeneric
02/2013
1Biomarkers (Surrogate Marker)IBA
12/2010

Therapy/Procedure

7Drug Therapy (Chemotherapy)
03/2020 - 09/2007
4Length of Stay
03/2020 - 12/2010
2Duration of Therapy
01/2020 - 09/2013
1Therapeutics
01/2020
1Continuity of Patient Care
01/2019
1Aftercare (After-Treatment)
01/2019
1Opiate Substitution Treatment
11/2013